Vaishali Pharma Limited (NSE:VAISHALI)
12.70
+0.36 (2.92%)
Aug 1, 2025, 3:29 PM IST
Vaishali Pharma Revenue
In the fiscal year ending March 31, 2025, Vaishali Pharma had annual revenue of 990.26M INR with 14.77% growth. Vaishali Pharma had revenue of 316.15M in the quarter ending March 31, 2025, a decrease of -2.41%.
Revenue
990.26M
Revenue Growth
+14.77%
P/S Ratio
1.55
Revenue / Employee
36.68M
Employees
27
Market Cap
1.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 990.26M | 127.46M | 14.77% |
Mar 31, 2024 | 862.80M | 166.17M | 23.85% |
Mar 31, 2023 | 696.63M | -61.58M | -8.12% |
Mar 31, 2022 | 758.21M | 220.47M | 41.00% |
Mar 31, 2021 | 537.74M | -63.12M | -10.50% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Fortis Healthcare | 77.86B |
Vaishali Pharma News
- 11 months ago - Vaishali Pharma shares surge 3% after company plans on ambitious growth strategy - Business Upturn
- 11 months ago - Vaishali Pharma to explore merger and acquisition strategy in upcoming board meeting on October 3 - Business Upturn
- 11 months ago - Vaishali Pharma Ltd (NSE:VAISHALI) Q3 2024 Earnings Call Transcript Highlights: Strong ... - GuruFocus